Verzenio (abemaciclib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Verzenio is used to treat advanced hormone-related breast cancer.
Verzenio is used for this condition only if your tumor tests negative for a protein called human epidermal growth factor receptor 2 (HER2). HER2 protein can speed the growth of cancer cells.
Verzenio is used when the cancer has progressed or has spread to other parts of the body after treatment with anti-estrogen medication or other chemotherapy.
When used in women, Verzenio is given with another medicine called fulvestrant.
